Antenatal Care for Low-Risk Pregnancy
For low-risk pregnant women, schedule 7-10 prenatal visits with the first visit by 14 weeks, followed by monthly visits until 28 weeks, every 2-4 weeks until 36 weeks, then weekly until delivery. 1, 2
Visit Schedule
The traditional U.S. schedule of 12-14 visits 3 exceeds what most peer countries recommend (7.5-10 visits) 2 and lacks strong evidence for improved outcomes. International data demonstrates that 7-10 visits for low-risk women achieve equivalent maternal and neonatal outcomes 4, though women may express less satisfaction with fewer visits 4.
Timing Pattern:
- First trimester: Every 4 weeks
- Second trimester: Every 2-4 weeks
- Third trimester: Every 1-2 weeks after 36 weeks 2
Critical caveat: Discontinuation of care before the third trimester increases preterm birth risk 12-fold (aOR = 12.6) 5, and gaps >21 days between visits nearly triple preterm birth risk (aOR = 2.87) 5.
Supplements
Folic Acid (Grade A Evidence)
All women must take 400 mcg daily starting before conception through the first trimester 6, 7. This reduces neural tube defects by 33% (RR 0.67) 8.
Iron
Evidence is insufficient to recommend routine supplementation for all pregnant women 10. The USPSTF found that while iron improves hematologic indices, subsequent improvement in maternal and infant outcomes has not been well-demonstrated 10. However, if anemia is identified, supplementation with 45-60 mg elemental iron daily is appropriate 9.
Other Supplements
- Vitamin D: Supplement to maintain levels ≥50 nmol/L 9
- Calcium: 1200-1500 mg daily (including dietary intake) 9
- Routine multivitamin use has limited evidence for improving outcomes 7
Vaccinations
Administer these immunizations as needed 6:
- Influenza (any trimester)
- Tdap (preferably 27-36 weeks)
- Hepatitis B (if not immune)
Contraindicated during pregnancy (give preconception if needed):
- MMR (measles, mumps, rubella)
- Varicella
Laboratory Screening
First Prenatal Visit (by 14 weeks) 1, 7
- Blood type and Rh status
- Complete blood count (hemoglobin/hematocrit for anemia)
- Syphilis screening
- HIV screening
- Hepatitis B surface antigen
- Rubella immunity
- Urinalysis and urine culture
Gestational Diabetes Screening
Insufficient evidence exists to recommend universal screening 11. The USPSTF found inadequate data on screening benefits for important outcomes like mortality, brachial plexus injury, and neonatal intensive care admissions 11.
However, ACOG recognizes that low-risk women (age <25, BMI ≤25, no high-risk ethnicity, no family history, no prior adverse outcomes) may not require glucose testing 11.
Each Trimester
- Repeat hemoglobin/hematocrit (though evidence for routine screening is insufficient 10)
Imaging
Ultrasound Examinations 12
- Midtrimester anatomy scan (18-23 weeks): Universal recommendation
- For low-risk women: Serial ultrasounds are not routinely indicated 13
- Routine antenatal testing has no evidence of benefit in low-risk pregnancies and may cause iatrogenic prematurity from false-positive results 13
Fetal Monitoring
After 24 weeks: Measure symphysis-fundal height at each visit (no more frequently than every 2 weeks) 1. This is the primary screening tool for fetal growth in low-risk women.
Counseling Topics
Essential Education 6, 14, 7
- Tobacco cessation: Maternal smoking increases stillbirth (RR 1.46), neonatal death (RR 1.22), and perinatal death (RR 1.33) 8
- Alcohol abstinence: Complete avoidance recommended
- Cannabis and opioid cessation: Provide treatment (buprenorphine/methadone for opioid use disorder) 8
- Breastfeeding promotion: Structured programs are effective 7
- Nutrition and weight management: Weight loss recommended preconception if BMI ≥25 8
- Signs of preterm labor and when to seek care
- Normal pregnancy symptoms vs. warning signs
Psychosocial Screening 6, 2
- Intimate partner violence
- Depression and anxiety
- Housing and food insecurity
- Substance use disorders
Genetic Counseling 7
Offer to couples with:
- Family history of genetic disorders
- Previously affected fetus/child
- Recurrent miscarriage
- Advanced maternal age
Prenatal serum marker screening for neural tube defects and aneuploidy should be offered to all women 7.
Common Pitfalls
- Do not delay first visit beyond 14 weeks 1 - early risk assessment is critical
- Do not order routine ultrasounds for low-risk women beyond the anatomy scan - this increases false positives without improving outcomes 13
- Do not screen for gestational diabetes in truly low-risk women meeting all five low-risk criteria 11
- Do not allow gaps >21 days between visits - this significantly increases preterm birth risk 5
- Ensure continuity through third trimester - discontinuation before third trimester is the strongest predictor of preterm birth 5